The Impact of BCR-ABL Tyrosine Kinase Inhibitor Therapy on Renal Function in Patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A 2023 Cross-Sectional Study

Simple item page
dc.contributor.advisorAddisu M.
dc.contributor.authorZekarias Seifu
dc.date.accessioned2025-08-07T07:26:28Z
dc.date.available2025-08-07T07:26:28Z
dc.date.issued2024-03-03
dc.description.abstractBCR-ABL tyrosine kinase inhibitors are effective in treating various cancers, but concerns exist regarding their potential to cause kidney damage. This study investigated the association between tyrosine kinase inhibitors and renal toxicities in patients at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia.
dc.identifier.urihttps://etd.aau.edu.et/handle/123456789/6235
dc.language.isoen_US
dc.publisherAddis Ababa University
dc.subjecttherapy on renal function in patients
dc.titleThe Impact of BCR-ABL Tyrosine Kinase Inhibitor Therapy on Renal Function in Patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A 2023 Cross-Sectional Study
dc.typeThesis

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Zekarias Seifu.pdf
Size:
456.69 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Internal Medicine